Short answer
Tvardi Therapeutics, Inc. (TVRD) filed an 8-K current report with the SEC on June 11, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Imran Alibhai, Cynthia Smith and Sujal Shah elected as Class II directors through the 2029 annual meeting.
Tvardi Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Imran Alibhai, Cynthia Smith and Sujal Shah elected as Class II directors through the 2029 annual meeting
- Executive compensation approved on an advisory basis, with 3,482,265 votes for and 161,795 against
- Annual executive-compensation advisory votes selected as preferred frequency, based on 3,453,729 votes
- Deloitte & Touche LLP ratified as independent auditor for fiscal 2026, with 6,523,292 votes for and 62,646 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tvardi Therapeutics, Inc. 8-K filings
Get the next TVRD 8-K as it lands
Follow TVRD for push alerts, or ask the research agent what this filing means.